赵磊 - 山东第一医科大学

个人简介

1998年毕业于原山东医科大学临床医学专业；2004年毕业于复旦大学上海医学院（原上海医科大学）外科学专业，获博士学位，师从我国肝癌研究泰斗汤钊猷院士；同年于山东省肿瘤医院肝胆外科参加工作。2007-2008年作为访问学者于美国国立癌症研究所（NCI）学习；2008-2012年于英国牛津大学肿瘤系，Churchill医院任Fellow、博士后。

研究领域

主要从事肝胆胰腺肿瘤的外科临床工作；主要研究方向为原发性与转移性肝癌的基础与临床研究。

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1.Zhao L, Wong LL, Shi X, Ji J. Should hepatic dysplasia nodules and regenerative nodules be regarded as pre-malignant lesions and treated? Hepatology. 2016 Oct;64(4):1370 DOI: 10.1002/hep.28444（第一及通讯作者；5年IF11.864） 2.Zhang C, Zhang W, Mu D, Shi X, Zhao, L. A clear cell adenocarcinoma of the gallbladder with hepatoid differentiation: case report and review of literature. Onco Targets Ther. 2016 Sep 22;9:5797 (通讯作者; 5年IF 2.235 ) 3.Zhang C, Shi X, Zhao L. Synchronous giant hepatic adenoma in siblings-A case report and brief literature review. Cancer Biol Ther. 2016 Jul 2;17(7):727 (通讯作者; 5年IF 3.396 ) 4.Zhong J, Zhao L, Zhou W, Li L, Shi X. Significance of the POSSUM Scoring System in Predicting Morbidity and Mortality in Elderly Patients after Pancreatoduodenectomy. Hepatogastroenterology. 2013 Jan 3;60(125). doi: 10.5754/hge121020.（5年IF0.867） 5.Zhao L, Lim SY, Gordon-Weeks AN, Cao Y, Beech J, Allen D, Smart S, Muschel RJ. Recruitment of a myeloid cell subset (CD11b/Gr1mid) via CCL2/CCR2 promotes the development of colorectal cancer liver me-x-tastasis. Hepatology. 2013. 57(2): p. 829-39. (5年IF11.864；被生物医学顶级论文推荐系统F1000 prime推荐) 6.Lim SY, Gordon-Weeks AN, Zhao L, et al. Recruitment of myeloid cells to the tumor microenvironment supports liver me-x-tastasis. Oncoimmunology. 2013 Mar 1;2(3):e23187. （5年IF 6.885） 7.Kong L, Zhu J, Han W, Jiang X, Xu M, Zhao Y, Dong Q, Pang Z, Guan Q, Gao L, Zhao J, Zhao L.Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 2011;48(1): 61-9. (通讯作者；5年IF 2.769；为该杂志2011年度被引用频次最高的5篇文章之一，获主编来信感谢；至2016年10月Thomson ReutersTM Web of ScienceTM检索被引153次，其中在Web of Science Core Collection引用139次) 8.Ji J, Zhao L, Budhu A, et al. Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol. 2010;52(5):690-7. (共同第一作者，5年IF 10.548；至2016年10月Thomson ReutersTM Web of ScienceTM检索被引105次，其中在Web of Science Core Collection引用97次) 9.Gil-Bernabe, A.M., S. Ferjancic, M. Tlalka, L. Zhao, P.D. Allen, J.H. Im, K. Watson, S.A. Hill, A. Amirkhosravi, J.L. Francis, J.W. Pollard, W. Ruf, and R.J. Muschel, Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for me-x-tastatic cell survival and preme-x-tastatic niche establishment in mice. Blood. 2012; 119(13): 3164-75. (5年IF 10.235) 10.Zhao L, Qin LX, Ye QH, et al. KIAA0008 gene is associated with invasive phenotype of human hepatocellular carcinoma-a functional analysis. J Cancer Res Clin Oncol. 2004;130(12):719-27. (影响因子2.409) 11.Li Y, Tian B, Yang J, Zhao L, et al. Stepwise me-x-tastatic human hepatocellular carcinoma cell model system with multiple me-x-tastatic potentials established through consecutive in vivo selection and studies on me-x-tastatic characteristics. J Cancer Res Clin Oncol. 2004;130(8):460-8. (影响因子2.409) 12.Zhang H, Ye QH, Ren N, Zhao L, et al. The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma. J Cancer Res Clin Oncol. 2006; 132(11):709-17. (影响因子2.469)